Text Registration
Copyright Title
Drug Evaluation 3rd edition by Shayne Cox Gad ( 9781119097396) 3
Status
Published
on 30 Nov 2016
Year of Creation
2016
Copyright Claimant
John Wiley & Sons, Inc
Registration Number
TX0008350388
on 30 Nov 2016Copyright Summary
The U.S. Copyright record (Registration Number: TX0008350388) dated 30 Nov 2016, pertains to an electronic file (eService) titled "Drug Evaluation 3rd edition by Shayne Cox Gad ( 9781119097396) 3" created in 2016. The copyright holder is John Wiley & Sons, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to John Wiley & Sons, Inc.
Application Details
Registration Number
TX0008350388
Registration Date
11/30/2016
Year of Creation
2016
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
John Wiley & Sons
Physical Description
Book, 822 p
First Publication Nation
United States
ISBN
9781119097396
Preexisting Material
previous editions
Notes
Material Matter Claimed Note: text, preface
Previous Registration Note: TX 7-333-912
Statements
Application Title Statement: Drug Evaluation 3rd edition by Shayne Cox Gad ( 9781119097396) 3
Author Statement: John Wiley & Sons employer for hire Domicile: United States Authorship: text, preface
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.